Determination of SNX-2112, a selective Hsp90 inhibitor, in plasma samples by high-performance liquid chromatography and its application to pharmacokinetics in rats
2010
Abstract A sensitive and specific reversed-phase high-performance liquid chromatography method with ultraviolet detection has been developed and validated for the identification and quantification of SNX-2112 in rat plasma. Following sample preparation using liquid–liquid extraction, the analytes were separated by the mobile phase acetonitrile–water (40:60, v/v) with an Agilent RP-HPLC column (ZORBAX SB-C18, 5 μm, 4.6 mm × 250 mm) at a flow rate of 1 ml/min, column temperature of 30 °C and detection wavelength of 251 nm. The retention time of SNX-2112 was 11.2 min. A good linear relationship was obtained in the concentration range studied (0.07–21 μg/ml, R 2 > 0.9982), and the LLOD and LLOQ for SNX-2112 were 0.02 and 0.07 μg/ml, respectively. The mean absolute recovery of SNX-2112 in plasma ranged from 88.58 to 99.61% at the studied concentrations. The intra- and inter-batch relative standard deviations were 1.7–3.5 and 1.9–4.4%, respectively. This method was successfully applied to pharmacokinetic studies in rats after intravenous administration of SNX-2112.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
14
References
10
Citations
NaN
KQI